270 related articles for article (PubMed ID: 30361074)
21. Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.
Harrell CR; Gazdic M; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
Curr Stem Cell Res Ther; 2019; 14(4):327-336. PubMed ID: 30806325
[TBL] [Abstract][Full Text] [Related]
22. Exosomes derived from bone marrow mesenchymal stem cells improve osteoporosis through promoting osteoblast proliferation via MAPK pathway.
Zhao P; Xiao L; Peng J; Qian YQ; Huang CC
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3962-3970. PubMed ID: 29949171
[TBL] [Abstract][Full Text] [Related]
23. MSC exosome works through a protein-based mechanism of action.
Toh WS; Lai RC; Zhang B; Lim SK
Biochem Soc Trans; 2018 Aug; 46(4):843-853. PubMed ID: 29986939
[TBL] [Abstract][Full Text] [Related]
24. Exosomes as potential alternatives to stem cell therapy for intervertebral disc degeneration: in-vitro study on exosomes in interaction of nucleus pulposus cells and bone marrow mesenchymal stem cells.
Lu K; Li HY; Yang K; Wu JL; Cai XW; Zhou Y; Li CQ
Stem Cell Res Ther; 2017 May; 8(1):108. PubMed ID: 28486958
[TBL] [Abstract][Full Text] [Related]
25. The impact of exosomes derived from B-cell acute lymphoblastic leukemia as a growth factor on bone marrow mesenchymal stromal cells.
Amirpour M; Kuhestani-Dehaghi B; Kheyrandish S; Hajipirloo LK; Khaffafpour Z; Keshavarz F; Allahbakhshian-Farsani M
Mol Biol Rep; 2024 Jun; 51(1):749. PubMed ID: 38874800
[TBL] [Abstract][Full Text] [Related]
26. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway.
Du Y; Li D; Han C; Wu H; Xu L; Zhang M; Zhang J; Chen X
Cell Physiol Biochem; 2017; 43(2):611-625. PubMed ID: 28934733
[TBL] [Abstract][Full Text] [Related]
27. Amniotic fluid stem cell exosomes: Therapeutic perspective.
Beretti F; Zavatti M; Casciaro F; Comitini G; Franchi F; Barbieri V; La Sala GB; Maraldi T
Biofactors; 2018 Mar; 44(2):158-167. PubMed ID: 29341292
[TBL] [Abstract][Full Text] [Related]
28. Amniotic fluid mesenchymal stromal cells from early stages of embryonic development have higher self-renewal potential.
Huang J; Ma W; Wei X; Yuan Z
In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):701-714. PubMed ID: 33029689
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal Stem Cell-Derived Exosomes Promote Fracture Healing in a Mouse Model.
Furuta T; Miyaki S; Ishitobi H; Ogura T; Kato Y; Kamei N; Miyado K; Higashi Y; Ochi M
Stem Cells Transl Med; 2016 Dec; 5(12):1620-1630. PubMed ID: 27460850
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth.
Lopez-Verrilli MA; Caviedes A; Cabrera A; Sandoval S; Wyneken U; Khoury M
Neuroscience; 2016 Apr; 320():129-39. PubMed ID: 26851773
[TBL] [Abstract][Full Text] [Related]
31. Postnatal fate of donor mesenchymal stem cells after transamniotic stem cell therapy in a healthy model.
Tracy SA; Chalphin AV; Lazow SP; Kycia I; Finkelstein A; Chan C; Zurakowski D; Fauza DO
J Pediatr Surg; 2020 Jun; 55(6):1113-1116. PubMed ID: 32164983
[TBL] [Abstract][Full Text] [Related]
32. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery.
Hauser PV; De Fazio R; Bruno S; Sdei S; Grange C; Bussolati B; Benedetto C; Camussi G
Am J Pathol; 2010 Oct; 177(4):2011-21. PubMed ID: 20724594
[TBL] [Abstract][Full Text] [Related]
33. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta.
In 't Anker PS; Scherjon SA; Kleijburg-van der Keur C; de Groot-Swings GM; Claas FH; Fibbe WE; Kanhai HH
Stem Cells; 2004; 22(7):1338-45. PubMed ID: 15579651
[TBL] [Abstract][Full Text] [Related]
34. [Bone marrow mesenchymal stem cell-derived exosome protects kidney against ischemia reperfusion injury in rats].
Wang R; Lin M; Li L; Li L; Qi G; Rong R; Xu M; Zhu T
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(42):3298-303. PubMed ID: 25622627
[TBL] [Abstract][Full Text] [Related]
35. An improvised one-step sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cells.
Gupta S; Rawat S; Arora V; Kottarath SK; Dinda AK; Vaishnav PK; Nayak B; Mohanty S
Stem Cell Res Ther; 2018 Jul; 9(1):180. PubMed ID: 29973270
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid.
Nadri S; Soleimani M
Cytotherapy; 2007; 9(8):729-37. PubMed ID: 17917881
[TBL] [Abstract][Full Text] [Related]
37. Donor mesenchymal stem cell linetics after transamniotic stem cell therapy (TRASCET) for experimental spina bifida.
Shieh HF; Ahmed A; Rohrer L; Zurakowski D; Fauza DO
J Pediatr Surg; 2018 Jun; 53(6):1134-1136. PubMed ID: 29580785
[TBL] [Abstract][Full Text] [Related]
38. Characterization and hepatogenic differentiation of mesenchymal stem cells from human amniotic fluid and human bone marrow: a comparative study.
Zheng YB; Gao ZL; Xie C; Zhu HP; Peng L; Chen JH; Chong YT
Cell Biol Int; 2008 Nov; 32(11):1439-48. PubMed ID: 18782626
[TBL] [Abstract][Full Text] [Related]
39. Transamniotic stem cell therapy (TRASCET) for intrauterine growth restriction (IUGR): A comparison between placental and amniotic fluid donor mesenchymal stem cells.
Whitlock AE; Moskowitzova K; Kycia I; Zurakowski D; Fauza DO
J Pediatr Surg; 2023 Feb; 58(2):305-309. PubMed ID: 36372622
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic alterations in amniotic fluid mesenchymal stem cells derived from normal and fetus-affected gestations: A focus on myogenic and neural differentiations.
Gasiūnienė M; Zentelytė A; Treigytė G; Baronaitė S; Savickienė J; Utkus A; Navakauskienė R
Cell Biol Int; 2019 Mar; 43(3):299-312. PubMed ID: 30635962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
